Novel therapy for Hodgkin lymphoma. [electronic resource]
Producer: 20140722Description: 394-9 p. digitalISSN:- 1520-4383
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- genetics
- Brentuximab Vedotin
- Hodgkin Disease -- drug therapy
- Humans
- Immunoconjugates -- therapeutic use
- Janus Kinases -- genetics
- NF-kappa B -- genetics
- Phosphatidylinositol 3-Kinases -- genetics
- STAT Transcription Factors -- genetics
- Signal Transduction -- drug effects
- Tumor Microenvironment
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.